Hypertension Devices Will Get US FDA Panel Focus

FDA has set a panel meeting date in December that will include discussion of trial designs and potential indications for devices being developed to treat hypertension. Also, the advisory panel will look at an implantable device seeking approval for use in heart-failure patients.

Despite some significant clinical-trial challenges, focus remains high in industry on developing devices to treat hypertension. US FDA is looking to stay ahead of the progress with a newly scheduled Dec. 5 meeting of its Circulatory System Devices Panel.

"Clinical studies to evaluate the safety and effectiveness of these devices are progressing," the agency said in the Oct. 26 meeting notice. "FDA requests panel input regarding the potential indications...

More from Regulation

More from Policy & Regulation